Omalizumab treatment of systemic mast cell activation disease: experiences from four cases.
Saved in:
| Title: | Omalizumab treatment of systemic mast cell activation disease: experiences from four cases. |
|---|---|
| Authors: | Molderings GJ; Institute of Human Genetics, University Hospital of Bonn, Germany. molderings@uni-bonn.de, Raithel M, Kratz F, Azemar M, Haenisch B, Harzer S, Homann J |
| Source: | Internal medicine (Tokyo, Japan) [Intern Med] 2011; Vol. 50 (6), pp. 611-5. Date of Electronic Publication: 2011 Mar 15. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 21422688 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Omalizumab treatment of systemic mast cell activation disease: experiences from four cases. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Molderings+GJ%22">Molderings GJ</searchLink>; Institute of Human Genetics, University Hospital of Bonn, Germany. molderings@uni-bonn.de<br /><searchLink fieldCode="AU" term="%22Raithel+M%22">Raithel M</searchLink><br /><searchLink fieldCode="AU" term="%22Kratz+F%22">Kratz F</searchLink><br /><searchLink fieldCode="AU" term="%22Azemar+M%22">Azemar M</searchLink><br /><searchLink fieldCode="AU" term="%22Haenisch+B%22">Haenisch B</searchLink><br /><searchLink fieldCode="AU" term="%22Harzer+S%22">Harzer S</searchLink><br /><searchLink fieldCode="AU" term="%22Homann+J%22">Homann J</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229204241%22">Internal medicine (Tokyo, Japan)</searchLink> [Intern Med] 2011; Vol. 50 (6), pp. 611-5. <i>Date of Electronic Publication: </i>2011 Mar 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Japanese+Society+of+Internal+Medicine%22">Japanese Society of Internal Medicine </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9204241 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1349-7235 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209182918%22">09182918 </searchLink><i>NLM ISO Abbreviation: </i>Intern Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=21422688 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2169/internalmedicine.50.4640 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 611 Titles: – TitleFull: Omalizumab treatment of systemic mast cell activation disease: experiences from four cases. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Molderings GJ – PersonEntity: Name: NameFull: Raithel M – PersonEntity: Name: NameFull: Kratz F – PersonEntity: Name: NameFull: Azemar M – PersonEntity: Name: NameFull: Haenisch B – PersonEntity: Name: NameFull: Harzer S – PersonEntity: Name: NameFull: Homann J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2011 Type: published Y: 2011 Identifiers: – Type: issn-electronic Value: 1349-7235 Numbering: – Type: volume Value: 50 – Type: issue Value: 6 Titles: – TitleFull: Internal medicine (Tokyo, Japan) Type: main |
| ResultId | 1 |